⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
PHIO News
Phio Pharmaceuticals Corp. Common Stock
Phio Pharmaceuticals Announces INTASYL PH-762 is Named Immunomodulatory Solution of the Year in the BioTech Breakthrough Award Program
newsfilecorp.com
PHIO
Phio Pharmaceuticals Announces Exercise of Warrants for Approximately $13.4 Million Gross Proceeds
newsfilecorp.com
PHIO
Phio Pharmaceuticals Announces Positive Pathology Results: Final Maximum Dose Cohort for INTASYL PH-762 Skin Cancer Trial
newsfilecorp.com
PHIO